A researcher who was awarded a $2 million dollar grant last year from the Cancer Prevention and Research Institute of Texas intentionally falsified data in previously published studies, according to the federal agency that oversees misconduct in research.

The Office of Research Integrity said in a report this week that Colleen Skau selectively omitted data, overstated numbers and falsified measurements that were included in studies published in the official journal of the National Academy of Sciences in 2015 and the peer-reviewed research journal Cell in 2016 . At the time, she was a postdoctoral researcher at the National Institutes of Health.

She is currently facing administrative action by U.S. Health and Human Services.

The Cancer Prevention and Research Institute of Texas has financially supported oncology research and prevention programs at institutions across the state for about a decade.

Last year, Skau was one of eight academics who were awarded a total of $16 million in recruitment grants to become first-time, tenure track faculty members. Her research focused on trying to understand what causes melanoma cells to metastasize. She was slated to work at the University of Texas Southwestern Medical Center, according to a press release issued in May.

After being notified of the retraction and subsequent review by the NIH, UT Southwestern said it withdrew the offer in July, prior to Skau being hired for the role, and it notified CPRIT.

Created in 2007, CPRIT has been the state’s major funder of cancer research, but the agency was mired in scandal in the early 2010s after a series of questionable grants.

In 2013, the state Legislature put in place additional oversight and revamped the agency. Its $3 billion budget allocation runs out in 2023.

Correction: February 22, 3:57 p.m.: A previous version of this story said the budget allocation for CPRIT runs out in 2021. Last year, the Legislature voted to extend it to 2023.